Cargando…
Safety and efficacy of intravenous infusion of allogeneic cryopreserved mesenchymal stem cells for treatment of chronic kidney disease in cats: results of three sequential pilot studies
INTRODUCTION: Administration of mesenchymal stem cells (MSCs) has been shown to improve renal function in rodent models of chronic kidney disease (CKD), in part by reducing intrarenal inflammation and suppressing fibrosis. CKD in cats is characterized by tubulointerstitial inflammation and fibrosis,...
Autores principales: | Quimby, Jessica M, Webb, Tracy L, Habenicht, Lauren M, Dow, Steven W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707049/ https://www.ncbi.nlm.nih.gov/pubmed/23632128 http://dx.doi.org/10.1186/scrt198 |
Ejemplares similares
-
Intensive Intravenous Infusion of Insulin in Diabetic Cats
por: Hafner, M., et al.
Publicado: (2014) -
Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger’s disease)
por: Martin-Rufino, Jorge D., et al.
Publicado: (2018) -
Allogeneic Human Mesenchymal Stem Cell Infusions for Aging Frailty
por: Golpanian, Samuel, et al.
Publicado: (2017) -
Neither COVID-19, nor cryopreservation, prevented allogeneic product infusion: A report from the National Marrow Donor Program
por: Farhadfar, Nosha, et al.
Publicado: (2022) -
Assessment of peritubular capillary rarefaction in kidneys of cats with chronic kidney disease
por: Paschall, Rene E., et al.
Publicado: (2023)